Dr. Bradley Heltemes, VP and medical director of R&D at Munich Re Life US, and Dr. Tim Meagher, Vice President and Medical Director Munich Re, Canada (Life) discuss how AI and technology are playing a more prominent role in the life insurance sector and improving cancer patient outcomes.
- Next Chubb CEO calls for US policy coherence to stop tariff confusion
- Previous How effective is UBI in reducing distracted driving?
Recent Posts
- Florida insurer Slide files for IPO disclosing growing revenue
- AI is changing insurance strategies for small businesses
- Why AI is no longer optional in non-standard auto insurance
- Why AI is no longer optional in non-standard auto insurance
- MGAs: Turning financial infrastructure into a strategic advantage
